BIONET Corp. (TPEX:1784)

BIONET Revenue

BIONET had revenue of 338.35M TWD in the quarter ending June 30, 2026, with 11.15% growth. This brings the company's total for the last twelve months to 1.29B, up 5.41% year-over-year. In the year 2025, BIONET had annual revenue of 1.24B with 1.19% growth. That makes BIONET the 29,618th largest company in the world by revenue and 1,433rd in Taiwan.

• Revenue (ttm): 1.29B
• Revenue Growth: +5.41%
• P/S Ratio: 1.77
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 2.29B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Stem Cells and Genetic Testing Products 1.21B 83.1%
• Other Departments 246.30M 16.9%

By Geography

Chart

• Taiwan 1.21B 98.1%
• Other 23.05M 1.9%

Fiscal year ended Dec 31, 2025 See the full BIONET breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.24B	14.57M	1.19%
Dec 31, 2024	1.22B	94.73M	8.40%
Dec 31, 2023	1.13B	146.93M	14.99%
Dec 31, 2022	980.38M	58.96M	6.40%
Dec 31, 2021	921.42M	114.85M	14.24%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error